Alternative Access First Priority CLO Bond ETF Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison

Sell

20

AAA
Alternative Access First Priority CLO Bond ETF

Last Price:

$24.97

Seasonality Move:

-0.16%

Sell

38

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:

$53.22

Seasonality Move:

-13.28%

Sell

20

Alternative Access First Priority CLO Bond ETF (AAA) is a Sell

Is Alternative Access First Priority CLO Bond ETF a Buy, Sell or Hold?

The current Alternative Access First Priority CLO Bond ETF [AAA] share price is $24.96. The Score for AAA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
AAA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

38

Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?

The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.34. The Score for CRNX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AAA Stock Price Chart

What is Alternative Access First Priority CLO Bond ETF's stock price today?

The Alternative Access First Priority CLO Bond ETF share price today is $24.96

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AAA is experiencing slight selling pressure.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals, Inc.'s stock price today?

The Crinetics Pharmaceuticals, Inc. share price today is $53.34

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing buying pressure, which is a positive indicator for future bullish movement.

AAA Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.01	Sell
Relative Strength Index (14 RSI):	45.22	Sell
Chaikin Money Flow:	-4113	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(24.97 - 25.03)	Sell
Bollinger Bands (100):	(24.98 - 25.06)	Sell

CRNX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.96	Buy
Relative Strength Index (14 RSI):	66.03	Buy
Chaikin Money Flow:	3428689	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(46.13 - 49.63)	Buy
Bollinger Bands (100):	(35.09 - 47.19)	Buy

AAA Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	24.99	Sell
20-day SMA:	25	Sell
50-day SMA:	25.01	Sell
200-day SMA:	24.98	Sell
8-day EMA:	24.98	Sell
20-day EMA:	25	Sell
50-day EMA:	25.01	Sell
200-day EMA:	25.01	Sell

CRNX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	48.2	Buy
20-day SMA:	48.28	Buy
50-day SMA:	45.42	Buy
200-day SMA:	36	Buy
8-day EMA:	48.68	Buy
20-day EMA:	47.84	Buy
50-day EMA:	45.56	Buy
200-day EMA:	40.15	Buy

Alternative Access First Priority CLO Bond ETF Earnings Growth & AAA Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.55 per share.

Alternative Access First Priority CLO Bond ETF Technical Analysis

	Dec 19	Dec 22	Dec 24	Dec 26	Dec 29	Dec 30	Dec 31	Jan 5	Jan 6	Jan 7
	Dec								Jan
	19	22	24	26	29	30	31	05	06	07
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals, Inc. Technical Analysis

	Dec 22	Dec 23	Dec 24	Dec 26	Dec 29	Dec 30	Dec 31	Jan 5	Jan 6	Jan 7
	Dec								Jan
	22	23	24	26	29	30	31	05	06	07
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):